We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61M
AUM Growth
-$5.18M
Cap. Flow
-$7.91M
Cap. Flow %
-12.97%
Top 10 Hldgs %
40.21%
Holding
93
New
23
Increased
18
Reduced
20
Closed
29

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.7M
2
AMZN icon
Amazon
AMZN
+$1.55M
3
SCHW
Charles Schwab
SCHW
+$1.47M
4
BABA icon
Alibaba
BABA
+$1.38M
5
SYF icon
Synchrony
SYF
+$1.03M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.87M
2
UNH icon
UnitedHealth
UNH
+$2.81M
3
HCA icon
HCA Healthcare
HCA
+$2.53M
4
GILD icon
Gilead Sciences
GILD
+$2.26M
5
LLY icon
Eli Lilly
LLY
+$1.84M

Sector Composition

Rank Sector Weight
1 Healthcare 57.96%
2 Technology 8.38%
3 Industrials 7.42%
4 Financials 7.32%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
$3.96M 6.5%
46,558
+4,765
+11% +$405K
BMY icon
2
Bristol-Myers Squibb
BMY
$136B
$3.37M 5.52%
48,922
+14,279
+41% +$944K
AGN
3
DELISTED
Allergan plc
AGN
$3.05M 5.01%
9,769
-2,016
-17% -$600K
TEVA icon
4
Teva Pharmaceuticals
TEVA
$42.5B
$2.49M 4.09%
37,993
+7,801
+26% +$482K
PANW icon
5
Palo Alto Networks
PANW
$303B
$2.42M 3.96%
82,314
+28,854
+54% +$833K
AER icon
6
AerCap
AER
$23.2B
$2.11M 3.46%
48,829
+14,266
+41% +$597K
EW icon
7
Edwards Lifesciences
EW
$52B
$1.86M 3.04%
70,482
-20,730
-23% -$538K
MDCO
8
DELISTED
Medicines Co
MDCO
$1.81M 2.97%
48,493
+12,094
+33% +$457K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.24T
$1.79M 2.93%
+45,960
New +$1.7M
AMZN icon
10
Amazon
AMZN
$2.87T
$1.66M 2.72%
+49,140
New +$1.55M
VMC icon
11
Vulcan Materials
VMC
$35.6B
$1.62M 2.66%
17,096
+1,752
+11% +$170K
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.55M 2.55%
11,044
+2,908
+36% +$403K
SCHW
13
Charles Schwab
SCHW
$191B
$1.53M 2.51%
+46,441
New +$1.47M
BABA icon
14
Alibaba
BABA
$296B
$1.43M 2.35%
+17,610
New +$1.38M
UHS icon
15
Universal Health Services
UHS
$10.1B
$1.39M 2.28%
11,628
+635
+6% +$77.6K
HRTX icon
16
Heron Therapeutics
HRTX
$62M
$1.25M 2.05%
46,938
-5,009
-10% -$134K
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
$1.24M 2.03%
35,300
-11,979
-25% -$773K
ALDR
18
DELISTED
Alder Biopharmaceuticals
ALDR
$1.21M 1.99%
36,756
+13,831
+60% +$468K
AERI
19
DELISTED
Aerie Pharmaceuticals
AERI
$1.21M 1.98%
49,556
-170
-0.3% -$3.97K
AET
20
DELISTED
Aetna Inc
AET
$1.2M 1.96%
11,075
-2,815
-20% -$304K
ACOR
21
DELISTED
Acorda Therapeutics
ACOR
$1.2M 1.96%
233
+49
+27% +$214K
TXT icon
22
Textron
TXT
$14.3B
$1.1M 1.81%
26,272
+20,373
+345% +$842K
BMY icon
23
CALL
Bristol-Myers Squibb
BMY
$136B
$1.1M 1.81%
16,000
-29,100
-65% -$1.92M
LRCX icon
24
Lam Research
LRCX
$378B
$1.07M 1.75%
+134,420
New +$1.01M
SYF icon
25
Synchrony
SYF
$25.4B
$1M 1.64%
+32,910
New +$1.03M
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Partner Investment Management held 93 positions worth $61M, down 7.8% from $66.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Partner Investment Management withdrew a net $7.91M in Q4 2015, closing 29 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 69% a quarter earlier, followed by Technology and Industrials.

Against the trend, Partner Investment Management opened a new position in Alphabet (Google) Class A worth $1.79M.

  • Partner Investment Management's largest Q4 2015 buy was Alphabet (Google) Class A: 45,960 shares worth $1.79M.
  • Partner Investment Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $944K increase.
  • Partner Investment Management's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $2.81M.
  • Partner Investment Management fully exited Pfizer in Q4 2015, selling an estimated $2.87M.
  • Partner Investment Management's ten largest holdings make up 40% of its $61M portfolio in Q4 2015.
  • Partner Investment Management opened 23 new positions and closed 29 in Q4 2015.
  • Partner Investment Management's portfolio value fell 7.8% quarter-over-quarter to $61M.

Based on Partner Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.